Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia
Clinical trial NCT02069886 · WITHDRAWN
Trial details
- NCT number
- NCT02069886
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.